Literature DB >> 25913059

Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer.

X-J Wu1, R-L Miao1, Z-Y Li1, Z-D Bu1, L-H Zhang1, A-W Wu1, X-L Zong1, S-X Li1, F Shan1, X Ji1, H Ren1, J-F Ji2.   

Abstract

BACKGROUND: Gastric cancer is one of most common malignancies in the world. Currently the prognostic prediction is entirely based on the TNM staging system. In this study, we evaluated whether metastatic lymph node ratio (rN) at the time of surgery would improve the prognostic prediction in conjunction with the TNM staging system.
METHODS: This retrospective study includes 745 patients, who had been referred for surgery due to gastric cancer between 1995 and 2007 and had at least 15 lymph nodes examined at the time of surgery without preoperative treatment. Clinicopathologic features and overall survival were analyzed using univariate and multivariate modes to identify the risk factors for overall survival.
RESULTS: Median overall survival of all patients analyzed is 57.8 months and 5-year overall survival is 49.5%. Tumor site, macroscopic type, pTNM stage, and rN stage are identified as independent prognostic factors. Increased positive lymph node ratio correlates with shorter survival in all patients and in each T and N stage. In stage III gastric cancer patients, rN stage shows additional prognostic value on overall survival (p < 0.001).
CONCLUSIONS: rN stage is a simple and promising prognostic factor of gastric cancer after surgery in addition to the TNM stage system especially in stage III patients. But the independent prognostic value of rN stage in stage I, II and IV gastric cancer is yet to be determined.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gastric cancer; Lymph node ratio; Prognosis; TNM stage

Mesh:

Year:  2015        PMID: 25913059     DOI: 10.1016/j.ejso.2015.03.225

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  25 in total

Review 1.  Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?

Authors:  Linda Agolli; Riccardo Maurizi Enrici; Mattia Falchetto Osti
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Positive Lymph Node Ratio as an Indicator of Prognosis and Local Tumor Clearance in N3 Gastric Cancer.

Authors:  Shuhei Komatsu; Daisuke Ichikawa; Mahito Miyamae; Toshiyuki Kosuga; Kazuma Okamoto; Tomohiro Arita; Hirotaka Konishi; Ryo Morimura; Yasutoshi Murayama; Atsushi Shiozaki; Yoshiaki Kuriu; Hisashi Ikoma; Masayoshi Nakanishi; Hitoshi Fujiwara; Eigo Otsuji
Journal:  J Gastrointest Surg       Date:  2016-06-28       Impact factor: 3.452

Review 3.  Prognostic impact of nodal status and therapeutic implications.

Authors:  Katja Ott; Susanne Blank; Laura Ruspi; Margit Bauer; Leila Sisic; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-15

4.  Ethnicity-related differences in tumor immunity: a new possible explanation for gastric cancer prognostic variability?

Authors:  Daniele Marrelli; Karol Polom; Franco Roviello
Journal:  Transl Gastroenterol Hepatol       Date:  2016-03-16

5.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

6.  Is Sarcopenic Obesity an Indicator of Poor Prognosis in Gastric Cancer Surgery? A Cohort Study in a Western Population.

Authors:  V Rodrigues; F Landi; S Castro; R Mast; N Rodríguez; A Gantxegi; J Pradell; M López-Cano; M Armengol
Journal:  J Gastrointest Surg       Date:  2020-07-13       Impact factor: 3.452

7.  A long non-coding RNA signature to improve prognosis prediction of gastric cancer.

Authors:  Xiaoqiang Zhu; Xianglong Tian; Chenyang Yu; Chaoqin Shen; Tingting Yan; Jie Hong; Zheng Wang; Jing-Yuan Fang; Haoyan Chen
Journal:  Mol Cancer       Date:  2016-09-20       Impact factor: 27.401

8.  Predictive Value of Preoperative Sarcopenia in Patients with Gastric Cancer: a Meta-analysis and Systematic Review.

Authors:  Zhengdao Yang; Xin Zhou; Bin Ma; Yanan Xing; Xue Jiang; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2018-07-09       Impact factor: 3.452

9.  Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study.

Authors:  Oh Kyoung Kwon; Se Won Kim; Hyun-Dong Chae; Seung Wan Ryu; Ho Young Chung; Sang Woon Kim; Won Kee Lee; Wansik Yu
Journal:  Ann Surg Treat Res       Date:  2016-11-25       Impact factor: 1.859

10.  Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?-Time to Embrace a New Digit.

Authors:  Yu-Yin Liu; Wen-Liang Fang; Frank Wang; Jun-Te Hsu; Chun-Yi Tsai; Keng-Hao Liu; Chun-Nan Yeh; Tse-Ching Chen; Ren-Chin Wu; Cheng-Tang Chiu; Ta-Sen Yeh
Journal:  Oncologist       Date:  2016-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.